Central Precocious Puberty in a Patient With X-Linked Adrenal Hypoplasia Congenita and Xp21 Contiguous Gene Deletion Syndrome

Authors: Han‐Wook YooGu Hwan KimJeesuk YuJi Won KohSo Young Kang
Year: 2013
Times cited: 15

Key People For Central Precocious Puberty

Top KOLs in the world
Jean‐Claude *****
growth hormone turner syndrome precocious puberty
Gordon * *******
precocious puberty turner syndrome growth hormone
Najiba ******
precocious puberty klinefelter syndrome luteinizing hormone
Anders ****
growth factor semen quality serum levels
E **** *****
turner syndrome central precocious puberty diabetic ketoacidosis
Wilma *********
short stature growth hormone early puberty

Central precocious puberty in a patient with X-linked adrenal hypoplasia congenita and Xp21 contiguous gene deletion syndrome


X-linked adrenal hypoplasia congenita is caused by the mutation of DAX-1 gene (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1), and can occur as part of a contiguous gene deletion syndrome in association with glycerol kinase (GK) deficiency, Duchenne muscular dystrophy and X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) gene deficiency. It is usually associated with hypogonadotropic hypogonadism, although in rare cases, it has been reported to occur in normal puberty or even central precocious puberty. This study addresses a case in which central precocious puberty developed in a boy with X-linked adrenal hypoplasia congenita who had complete deletion of the genes DAX-1, GK and IL1RAPL1 (Xp21 contiguous gene deletion syndrome). Initially he was admitted for the management of adrenal crisis at the age of 2 months, and managed with hydrocortisone and florinef. At 45 months of age, his each testicular volumes of 4 mL and a penile length of 5 cm were noted, with pubic hair of Tanner stage 2. His bone age was advanced and a gonadotropin-releasing hormone (GnRH) stimulation test showed a luteinizing hormone peak of 8.26 IU/L, confirming central precocious puberty. He was then treated with a GnRH agonist, as well as steroid replacement therapy. In Korea, this is the first case of central precocious puberty developed in a male patient with X-linked adrenal hypoplasia congenita.

to see all concepts, it's free!